The Institute for Advancing Medical Innovation was designed to create an unprecedented collaboration of resources and processes to support the following key objectives:

• Translate innovative research into disruptive medical innovations and advance these discoveries through a series of "go or no-go" decision points for the benefit of patient care
• Advance new drug therapies, drug products and drug delivery platform technologies to patients through effective partnerships with other academic institutions, industry, government, disease philanthropy and nonprofit organizations
• Develop drug discovery, drug delivery, and bioengineering innovators who have skill sets, sense of urgency and access to resources necessary to drive medical innovation discoveries from the university to patients;
• Operate an Office of Project and Portfolio Management that will identify projects, create project teams and timelines, and work with the University of Kansas Innovation and Collaboration to create and enhance value proposition.